About 37,800 results
Open links in new tab
  1. Novel Iron-Lowering Drug Tied to Slowing of MSA Progression

    ATH434 improves daily function and reduces brain iron in patients with multiple system atrophy, a rare, fatal neurodegenerative disorder with no approved treatments.

  2. The Expanding Scope of the Respiratory Therapist - Medscape

    Nov 10, 2025 · Today’s RTs are earning different types of roles than their predecessors. How might the profession progress from here?

  3. Foetal Size Key Driver in Weight Estimation Accuracy - Medscape

    Ultrasound estimates of foetal weight are less accurate for foetuses with severe small for gestational age, with even greater inaccuracy at earlier gestational ages.

  4. Positive Esketamine Safety Profile at 5 Years - Medscape

    Sep 22, 2025 · Esketamine nasal spray appears safe for up to 5 years, with a low incidence of serious adverse events and no new safety signals, in new research.

  5. Long-Term Rimegepant Use Safe for Migraine Prevention - Medscape

    Jul 17, 2025 · Rimegepant 75 mg for 52 weeks is well tolerated, with no liver safety signals and a sustained reduction in monthly migraine days, a new extension study shows.

  6. Anticonvulsant Shows Promise for Obstructive Sleep Apnea

    The anticonvulsant sultiame was associated with improved symptoms among patients with obstructive sleep apnea (OSA), a phase 2 trial showed.

  7. New ASCO Guidelines for Advanced Ovarian Cancer - Medscape

    Feb 24, 2025 · ASCO’s updated guidelines for advanced ovarian cancer emphasize health equity and provide new recommendations for HIPEC while maintaining the core therapeutic principles described …

  8. Pembrolizumab for Advanced Melanoma: Is It Worth It? - Medscape

    May 9, 2025 · Despite a risk for severe side effects, pembrolizumab has a record of improving recurrence-free survival that makes it an appealing treatment for advanced melanoma.

  9. Sep 26 2025 This Week in Cardiology - Medscape

    Sep 26, 2025 · A bold trial in valvular heart disease, a CV prevention trial whose message is humility, VTE dogma challenged, more news on oral GLP-1 agonists, and a few public service …

  10. About Medscape

    Medscape is the leading online global destination for physicians and healthcare professionals worldwide, offering the latest medical news and expert perspectives; essential point-of-care drug and ...